Search

Your search keyword '"Gross, Catharina C"' showing total 499 results

Search Constraints

Start Over You searched for: Author "Gross, Catharina C" Remove constraint Author: "Gross, Catharina C"
499 results on '"Gross, Catharina C"'

Search Results

1. GateNet: A novel Neural Network Architecture for Automated Flow Cytometry Gating

4. Translational imaging of TSPO reveals pronounced innate inflammation in human and murine CD8 T cell–mediated limbic encephalitis

6. Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy

9. Classification of neurological diseases using multi-dimensional cerebrospinal fluid analysis

10. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis.

12. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

13. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

15. Immune signatures of prodromal multiple sclerosis in monozygotic twins

24. CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis

25. Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.

27. Secretomics reveals gelatinase substrates at the blood-brain barrier that are implicated in astroglial barrier function

32. Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories (P1-3.008)

34. Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases

35. CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome

37. Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response.

39. Prospective validation of the PML risk biomarker L-Selectin and influence of natalizumab extended intervals

46. Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease:A Case Series

48. Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound

49. A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis

50. Correction: Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis

Catalog

Books, media, physical & digital resources